p.113 抽出テキスト

final common pathway? Eur Heart J 2021; 42: 1073-1081. PMID: 33421051 342. Bezzina CR, Barc J, Mizusawa Y, et al. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. Nat Genet 2013; 45: 1044-1049. PMID: 23872634 343. Nakano Y, Ochi H, Onohara Y, et al. Common Variant Near HEY2 Has a Protective Effect on Ventricular Fibrillation Occurrence in Brugada Syndrome by Regulating the Repolarization Current. Circ Arrhythm Electrophysiol 2016; 9: e003436. PMID: 26729854 344. Jimmy Juang JM, Liu YB, Julius Chen CY, et al. Validation and Disease Risk Assessment of Previously Reported Genome-Wide Genetic Variants Associated With Brugada Syndrome: SADS-TW BrS Registry. Circ Genom Precis Med 2020; 13: e002797. PMID: 32490690 345. Makarawate P, Glinge C, Khongphatthanayothin A, et al. Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand. Heart Rhythm 2020; 17: 2145-2153. PMID: 32619740 346. Barc J, Tadros R, Glinge C, et al. KORA-Study Group. Genomewide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. Nat Genet 2022; 54: 232-239. PMID: 35210625 347. Cerrone M, Remme CA, Tadros R, et al. Beyond the One Gene-One Disease Paradigm: Complex Genetics and Pleiotropy in Inheritable Cardiac Disorders. Circulation 2019; 140: 595-610. PMID: 31403841 348. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 1999; 100: 1660-1666. PMID: 10517739 349. Meregalli PG, Wilde AA, Tan HL. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res 2005; 67: 367-378. PMID: 15913579 350. Sieira J, Dendramis G, Brugada P. Pathogenesis and management of Brugada syndrome. Nat Rev Cardiol 2016; 13: 744-756. PMID: 27629507 351. Nagase S, Kusano KF, Morita H, et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. J Am Coll Cardiol 2002; 39: 1992-1995. PMID: 12084598 352. Nademanee K, Hocini M, Haïssaguerre M. Epicardial substrate ablation for Brugada syndrome. Heart Rhythm 2017; 14: 457-461. PMID: 27979714 353. Kurita T, Shimizu W, Inagaki M, et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 2002; 40: 330-334. PMID: 12106940 354. Nagase S, Kusano KF, Morita H, et al. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome. J Am Coll Cardiol 2008; 51: 1154-1161. PMID: 18355652 355. Letsas KP, Vlachos K, Conte G, et al. Right ventricular outflow tract electroanatomical abnormalities in asymptomatic and highrisk symptomatic patients with Brugada syndrome: Evidence for a new risk stratification tool? J Cardiovasc Electrophysiol 2021; 32: 2997-3007. PMID: 34596938 356. Nagase S, Kataoka N, Morita H, et al. Demonstration of Arrhythmia Substrate-Associated Dispersion of Repolarization by Epicardial Unipolar Mapping in Brugada Syndrome. JACC Clin Electrophysiol 2024; 10: 1576-1588. PMID: 38864810 357. Kusano KF, Taniyama M, Nakamura K, et al. Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol 2008; 51: 1169-1175. PMID: 18355654 358. Makimoto H, Kamakura S, Aihara N, et al. Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram. Heart Rhythm 2012; 9: 242-248. PMID: 21939629 359. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Circulation 1991; 84: 1831- 1851. PMID: 1717173 360. Nattel S, Carlsson L. Innovative approaches to anti-arrhythmic drug therapy. Nat Rev Drug Discov 2006; 5: 1034-1049. PMID: 17139288 361. Wilde AA, Postema PG, Di Diego JM, et al. The pathophysiological mechanism underlying Brugada syndrome: depolarization versus repolarization. J Mol Cell Cardiol 2010; 49: 543-553. PMID: 20659475 362. Aiba T, Shimizu W, Hidaka I, et al. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study. J Am Coll Cardiol 2006; 47: 2074-2085. PMID: 16697328 363. Morita H, Zipes DP, Wu J. Brugada syndrome: insights of ST elevation, arrhythmogenicity, and risk stratification from experimental observations. Heart Rhythm 2009; 6 Suppl: S34-S43. PMID: 19880072 364. Matsuo K, Akahoshi M, Seto S, et al. Disappearance of the Brugada-type electrocardiogram after surgical castration: a role for testosterone and an explanation for the male preponderance. Pacing Clin Electrophysiol 2003; 26: 1551-1553. PMID: 12914638 365. Furukawa T, Kurokawa J. Regulation of cardiac ion channels via non-genomic action of sex steroid hormones: implication for the gender difference in cardiac arrhythmias. Pharmacol Ther 2007; 115: 106-115. PMID: 17583354 366. Asatryan B, Yee L, Ben-Haim Y, et al. Sex-Related Differences in Cardiac Channelopathies: Implications for Clinical Practice. Circulation 2021; 143: 739-752. PMID: 33587657 367. Ohkubo K, Watanabe I, Okumura Y, et al. Right ventricular histological substrate and conduction delay in patients with Brugada syndrome. Int Heart J 2010; 51: 17-23. PMID: 20145346 368. Miles C, Asimaki A, Ster IC, et al. Biventricular Myocardial Fibrosis and Sudden Death in Patients With Brugada Syndrome. J Am Coll Cardiol 2021; 78: 1511-1521. PMID: 34620408 369. Ikeda T, Sakurada H, Sakabe K, et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol 2001; 37: 1628- 1634. PMID: 11345376 370. Morita H, Kusano KF, Miura D, et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation 2008; 118: 1697-1704. PMID: 18838563 371. Morita H, Watanabe A, Morimoto Y, et al. Distribution and Prognostic Significance of Fragmented QRS in Patients With Brugada Syndrome. Circ Arrhythm Electrophysiol 2017; 10: e004765. PMID: 28314845 372. Szél T, Antzelevitch C. Abnormal repolarization as the basis for late potentials and fractionated electrograms recorded from epicardium in experimental models of Brugada syndrome. J Am Coll Cardiol 2014; 63: 2037-2045. PMID: 24657694 373. Adler A, Rosso R, Chorin E, et al. Risk stratification in Brugada syndrome: Clinical characteristics, electrocardiographic parameters, and auxiliary testing. Heart Rhythm 2016; 13: 299-310. PMID: 26341603 374. Ikeda T, Takami M, Sugi K, et al. Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest. Ann Noninvasive Electrocardiol 2005; 10: 396-403. PMID: 16255748 375. Delise P, Allocca G, Marras E, et al. Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J 2011; 32: 169-176. PMID: 20978016 376. Tokioka K, Kusano KF, Morita H, et al. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities. J Am Coll Cardiol 2014; 63: 2131-2138. PMID: 24703917 377. Okamura H, Kamakura T, Morita H, et al. Risk stratification in patients with Brugada syndrome without previous cardiac arrest – prognostic value of combined risk factors. Circ J 2015; 79: 310-317. PMID: 25428522 378. Conte G, de Asmundis C, Sieira J, et al. Prevalence and Clinical Impact of Early Repolarization Pattern and QRS-Fragmentation in High-Risk Patients With Brugada Syndrome. Circ J 2016; 80: 2109-2116. PMID: 27558008 379. Kawazoe H, Nakano Y, Ochi H, et al. Risk stratification of ventricular fibrillation in Brugada syndrome using noninvasive scoring methods. Heart Rhythm 2016; 13: 1947-1954. PMID: 27424075 380. Gonzalez Corcia MC, Sieira J, Pappaert G, et al. A Clinical Score Model to Predict Lethal Events in Young Patients ( ≤19 Years) With the Brugada Syndrome. Am J Cardiol 2017; 120: 797-802. PMID: 28728742 381. Takagi M, Sekiguchi Y, Yokoyama Y, et al. Japan Idiopathic Ventricular Fibrillation Study (J-IVFS) Investigators. The prognostic impact of single extra-stimulus on programmed ventricular stimulation in Brugada patients without previous cardiac arrest: multi-centre study in Japan. Europace 2018; 20: 1194-1200. PMID: 29016800